Galenica AG
SIX:GALE

Watchlist Manager
Galenica AG Logo
Galenica AG
SIX:GALE
Watchlist
Price: 96.6 CHF -0.21%
Market Cap: CHf4.8B

Net Margin

4.8%
Current
Declining
by 0.8%
vs 3-y average of 5.6%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
4.8%
=
Net Income
CHf192.3m
/
Revenue
CHf4B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
4.8%
=
Net Income
CHf192.3m
/
Revenue
CHf4B

Peer Comparison

Country Company Market Cap Net
Margin
CH
Galenica AG
SIX:GALE
4.8B CHF
Loading...
US
Mckesson Corp
NYSE:MCK
102.3B USD
Loading...
US
Amerisourcebergen Corp
LSE:0HF3
67.7B USD
Loading...
US
Cencora Inc
NYSE:COR
67.7B USD
Loading...
US
Cardinal Health Inc
NYSE:CAH
50B USD
Loading...
AU
Sigma Healthcare Ltd
ASX:SIG
35.5B AUD
Loading...
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
64.2B CNY
Loading...
CN
Huadong Medicine Co Ltd
SZSE:000963
63.6B CNY
Loading...
US
Henry Schein Inc
NASDAQ:HSIC
8.9B USD
Loading...
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
Loading...
CN
Sinopharm Group Co Ltd
HKEX:1099
66B HKD
Loading...

Market Distribution

In line with most companies in Switzerland
Percentile
43nd
Based on 1 179 companies
43nd percentile
4.8%
Low
-57 027.8% — 1.3%
Typical Range
1.3% — 13.7%
High
13.7% — 3 663.7%
Distribution Statistics
Switzerland
Min -57 027.8%
30th Percentile 1.3%
Median 7.2%
70th Percentile 13.7%
Max 3 663.7%

Galenica AG
Glance View

Market Cap
4.8B CHF
Industry
Health Care

In the picturesque landscape of Switzerland, Galenica AG operates as a stalwart in the healthcare sector, seamlessly bridging the gap between pharmaceutical production and retail distribution. Born from a deep-rooted legacy in delivering health solutions, Galenica combines its prowess in logistics with an extensive network of pharmacies spread across the country. The magic of Galenica's operations lies in its unique dual structure. On one hand, it operates a robust logistics arm, supplying a wide array of medicines to healthcare providers, hospitals, and pharmacies. On the other hand, it runs its own retail pharmacy chains, such as Amavita and Sun Store, alongside an e-commerce platform, which make pharmaceutical care more accessible and customer-friendly for the Swiss populace. Galenica's profitability thrives on this diversified business model. By owning the supply chain from logistics to retail, the company maximizes efficiency and reduces costs, positioning itself as a leader in the Swiss pharmaceutical market. Revenue streams flow from wholesale distribution contracts, retail pharmacy sales, and a growing presence in digital health services. Furthermore, in its operations, Galenica integrates a customer-centric philosophy, leveraging data analytics to optimize stock management and personalize customer experiences—effectively enhancing earnings and customer loyalty. Through meticulous execution and strategic expansion, Galenica ensures that it remains an indispensable player in Switzerland's healthcare framework.

GALE Intrinsic Value
106.57 CHF
Undervaluation 9%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
4.8%
=
Net Income
CHf192.3m
/
Revenue
CHf4B
What is Galenica AG's current Net Margin?

The current Net Margin for Galenica AG is 4.8%, which is below its 3-year median of 5.6%.

How has Net Margin changed over time?

Over the last 3 years, Galenica AG’s Net Margin has increased from 4.6% to 4.8%. During this period, it reached a low of 4.6% on May 30, 2022 and a high of 7.6% on Dec 31, 2023.

Back to Top